[Variations in the behavior in chronic hospitalized schizophrenics under treatment with EMD 16, 139, a benzoquinolizine derivative].
A group of hospitalized chronic schizophrenic patients was treated with EMD 16 139 - a benzochinolizin derivate - for 4 weeks in a placebo-controlled trial. Changes of behavior were measured using a rating scale. The results suggest an increase of activity and initiative during treatment. Problems concerning some neuroleptic effects are discussed.
D000328:Adult; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011807:Quinolizines / Q000008:administration & dosage / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D010919:Placebos; D011807:Quinolizines
Veränderung des Antriebs bei hospitalisierten chronisch Schizophrenen unter der Behandlung mit EMD 16 139, einem Benzochinolizinderivat